Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
2,450.22
3,239.64
3,185.93
3,107.65
3,335.53
3,400.56
2,953.12
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,450.22
3,239.64
3,185.93
3,107.65
3,335.53
3,400.56
2,953.12
Raw Material Cost
1,153.23
1,157.35
1,183.88
1,067.64
1,146.31
1,240.13
1,097.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.94
10.92
14.82
15.07
16.19
15.93
22.00
Selling and Distribution Expenses
607.08
954.07
1,203.05
1,090.37
1,144.94
1,005.12
1,005.73
Other Expenses
17.58
15.35
23.99
23.48
18.98
18.83
27.60
Total Expenditure (Excl Depreciation)
1,950.06
2,275.84
2,641.62
2,407.93
2,497.24
2,449.48
2,401.64
Operating Profit (PBDIT) excl Other Income
500.20000000000005
963.8
544.3
699.7
838.3
951.1
551.5
Other Income
55.90
41.16
0.46
61.16
160.13
119.87
205.95
Operating Profit (PBDIT)
691.53
1,142.01
572.67
886.66
1,116.95
1,192.35
741.55
Interest
13.94
10.92
14.82
15.07
16.19
15.93
22.00
Exceptional Items
24.83
-18.74
16.85
11.36
-9.47
0.88
-10.75
Gross Profit (PBDT)
1,296.99
2,082.29
2,002.05
2,040.01
2,189.22
2,160.43
1,855.20
Depreciation
182.85
179.26
171.72
171.06
169.06
167.53
155.42
Profit Before Tax
519.56
933.09
402.98
711.89
922.23
1,009.78
553.38
Tax
89.11
144.10
92.93
97.69
131.57
165.67
156.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
408.95
651.00
295.23
516.86
695.27
680.75
419.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
408.95
651.00
295.23
516.86
695.27
680.75
419.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
47.90
165.99
12.76
115.85
111.35
178.48
-32.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
456.85
816.99
308.00
632.71
806.63
859.23
387.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.16
1.13
1.11
1.09
1.1
1.07
1.06
Reserves
15,447.21
16,466.59
15,468.48
15,261.26
14,984.30
15,198.23
14,752.46
Earnings per share (EPS)
0.46
0.73
0.33
0.59
0.79
0.76
0.46
Diluted Earnings per share
0.46
0.73
0.33
0.59
0.79
0.76
0.46
Operating Profit Margin (Excl OI)
18.48%
28.45%
12.57%
21.06%
23.62%
26.61%
12.87%
Gross Profit Margin
28.67%
34.34%
18.04%
28.41%
32.72%
34.62%
24.0%
PAT Margin
16.69%
20.09%
9.27%
16.63%
20.84%
20.02%
14.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -26.54% vs 1.65% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -43.37% vs 17.00% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -33.57% vs -1.66% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -14.20% vs -35.97% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Livzon Pharmaceutical Group, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(HKD)
Change(%)
Net Sales
2,450.22
0
2,450.22
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,450.22
0
2,450.22
Raw Material Cost
1,153.23
0
1,153.23
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.94
0
13.94
Selling and Distribution Expenses
607.08
0
607.08
Other Expenses
17.58
0.00
17.58
Total Expenditure (Excl Depreciation)
1,950.06
0
1,950.06
Operating Profit (PBDIT) excl Other Income
500.15
0.00
500.15
Other Income
55.90
0
55.90
Operating Profit (PBDIT)
691.53
0
691.53
Interest
13.94
0
13.94
Exceptional Items
24.83
0
24.83
Gross Profit (PBDT)
1,296.99
0
1,296.99
Depreciation
182.85
0
182.85
Profit Before Tax
519.56
0
519.56
Tax
89.11
0
89.11
Provisions and contingencies
0
0
0.00
Profit After Tax
408.95
0
408.95
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
408.95
0
408.95
Share in Profit of Associates
0
0
0.00
Minority Interest
47.90
0
47.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
456.85
0
456.85
Equity Capital
0
0
0.00
Face Value
1.16
0
0.00
Reserves
15,447.21
0
15,447.21
Earnings per share (EPS)
0.46
0
0.46
Diluted Earnings per share
0.46
0
0.46
Operating Profit Margin (Excl OI)
18.48%
0%
0.00
18.48%
Gross Profit Margin
28.67%
0%
0.00
28.67%
PAT Margin
16.69%
0%
0.00
16.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 245.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -24.37% vs 1.69% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -26.54% vs 1.65% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 45.68 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -44.09% vs 165.26% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -43.37% vs 17.00% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.56 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -42.26% vs 92.38% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -33.57% vs -1.66% in Jun 2025
Quarterly - Interest
Interest 1.39 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 27.52% vs -26.35% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.20% vs -35.97% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.48%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
